Delivery Order SPE2DR25D1051-SPE2DR26F37E3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets in a quantity of 60 count, with a ceiling value of $1,012.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded through open competition without a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $1,187.00. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract with performance executed from the contractor's Conshohocken, Pennsylvania location. The award is a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $11,427.01. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,956,820 units of Clonidine HCl ER 0.1 mg tablets in 60-count packages. The $2,018.04 contract has a performance period through March 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCl ER 0.1 mg tablets (60-count) on August 27, 2025, with a ceiling value of $4,493.28 and an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCL ER 0.1 mg tablets (60-count) with a ceiling value of $2,304.37. The award was issued on July 17, 2025, with an ultimate completion date of July 18, 2025, and utilized firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,159.04 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes a firm fixed-price contract structure with no set-aside designation. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Clonidine HCl ER 0.17 mg tablets. The contract has a ceiling value of $4,590.39 and a completion date of June 21, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
- The Defense Logistics Agency awarded a delivery order valued at $2,184.18 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units). The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 8, 2025, for Clonidine HCl ER 0.17 mg tablets (30-count supply) with a ceiling value of $1,491.84. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 9, 2025, and involves no set-aside designation. The delivery order represents a single transaction under AmerisourceBergen's broader...
- SPE2DR25D1051Indefinite Delivery Contract
- SPE2DR25D1051-SPE2DR26F37E3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count packages) with a ceiling value of $10,418.83. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The contract specifies an ultimate completion date of October 24, 2025, and identifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard through this comprehensive global pharmaceutical support vehicle. The contract demonstrates the company's capability to supply an extensive range of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 10/23/25 |